食品科学 ›› 2017, Vol. 38 ›› Issue (11): 95-102.doi: 10.7506/spkx1002-6630-201711016

• 基础研究 • 上一篇    下一篇

基于网络药理学预测我国蜂胶改善代谢性疾病的生物学机制

应 剑,张 波,王春波,王春玲   

  1. 中粮营养健康研究院,北京 102209
  • 出版日期:2017-06-15 发布日期:2017-06-19

Systematic Analysis of Biological Mechanisms of Propolis in Improving Metabolic Health through a Network Pharmacological Approach

YING Jian, ZHANG Bo, WANG Chunbo, WANG Chunling   

  1. COFCO Nutrition and Health Research Institute, Beijing 102209, China
  • Online:2017-06-15 Published:2017-06-19

摘要: 为系统分析我国蜂胶改善2型糖尿病、肥胖等代谢性疾病的生物学机制,开发防控慢性代谢性疾病的标准化功能性食品提供科学参考,以我国蜂胶中的主要黄酮类、酚酸及酯类化合物成分为研究对象,利用结构相似比对法预测其作用靶点,并利用网络药理学方法建立“成分-靶标-疾病”的关联,阐述蜂胶成分改善代谢性疾病的“多成分、多靶点”特征,分析核心作用通路。通过与现有文献报道的对比分析,计算得到靶标预测成功率为86.2%。PPARγ、ESR1、ESR2、SIRT1、PTPN1是蜂胶化合物总体作用概率最高的靶标,其中PPARγ是黄酮类化合物与酚酸类化合物的共同重要靶标。蜂胶中的黄酮类化合物是与改善糖脂代谢活性关联最为密切的一类物质,此外部分酚酸及酯类化合物也发挥了协同作用。网络分析结果表明,蜂胶成分可能分别或者共同作用于糖脂代谢相关的多条通路,通过促进糖摄取、促进胰岛素分泌、改善胰岛素抵抗、促进脂代谢、抑制脂肪细胞分化等途径改善糖脂代谢。研究结果为我国蜂胶在改善代谢性疾病领域的应用及相关功能性食品活性成分标准的制定提供了参考。同时,本研究证明,结构相似比对结合网络药理学研究手段对于现代化功能性食品研发有重要的指引作用,可以在早期为复杂体系的物质基础及生物学机制研究提供科学证据。

关键词: 结构相似比对, 网络药理学, 蜂胶, 代谢性疾病, 黄酮类, 酚酸及酯类, 预测成功率

Abstract: Chronic metabolic diseases, such as type 2 diabetes and obesity, have brought a huge burden to our society. Certain functional foods could bring health benefits to people with metabolic abnormalities, and sometimes help delay the onset of metabolic diseases. Propolis is a traditional Chinese medicine, and has been used as a raw material of functional foods for quite a long time. Pharmacological studies and clinical trials have provided evidence that propolis and its active components could be promising candidates for improving metabolic health. In order to develop standardized functional foods with consistent quality and functions, a systemic view of the mechanism of action is required. We should also be aware that propolis is a combination of multiple active components. Network pharmacology is a recently developed method as an integrative system which enables a systemic investigation of interactions between multiple components and multiple targets. The method of network pharmacology has been used in studies of traditional Chinese medicine. In order to survey the molecular mechanisms of propolis components in treating metabolic diseases, we use structural similarity search to predict therapeutic targets of propolis flavonoids, phenolic acids and esters, and to construct a ‘component-target-disease’ network. Comparing with published data, we calculated that the success ratio of prediction was 86.2%. Based on the network, we concluded that PPARγ, ESR1, ESR2, SITR1 and PTPN1 are key targets of propolis. PPARγ is the most important target for both flavonoids and phenolic acids. Propolis flavonoids and some phenolic acids and esters contribute to the regulation of glucose and lipid metabolism by propolis through various pathways such as lipid metabolism, adipocyte differentiation, insulin secretion and insulin resistance. Based on the results of our study, we introduced a new research tool that can be used in the early stage of functional food development. We found that network pharmacology could provide information for formulating product standards for functional foods, which is important for innovation and upgrading of food industry.

Key words: structural similarity search, network pharmacology, propolis, metabolic diseases, flavonoids, phenolic acids and esters, prediction ratio

中图分类号: